These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

749 related articles for article (PubMed ID: 12111748)

  • 1. Candida dubliniensis, a new fungal pathogen.
    Gutiérrez J; Morales P; González MA; Quindós G
    J Basic Microbiol; 2002; 42(3):207-27. PubMed ID: 12111748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection and antifungal susceptibility testing of oral Candida dubliniensis from human immunodeficiency virus-infected patients.
    Chunchanur SK; Nadgir SD; Halesh LH; Patil BS; Kausar Y; Chandrasekhar MR
    Indian J Pathol Microbiol; 2009; 52(4):501-4. PubMed ID: 19805956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Candida dubliniensis in a diagnostic microbiology laboratory.
    Momani OM; Qaddoomi A
    East Mediterr Health J; 2005 May; 11(3):366-71. PubMed ID: 16602455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Candida dubliniensis studies and isolation of Candida types in oropharyngeal specimens from oncologic patients].
    Tekeli A; Dolapçi I; Cesur S; Tekeli E; Içli F
    Mikrobiyol Bul; 2002 Jan; 36(1):57-63. PubMed ID: 12476767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Candida dubliniensis in a study of HIV-seropositive pediatric dental patients.
    Brown DM; Jabra-Rizk MA; Falkler WA; Baqui AA; Meiller TF
    Pediatr Dent; 2000; 22(3):234-8. PubMed ID: 10846737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Identification of Candida dubliniensis strains using heat tolerance tests, morphological characteristics and molecular methods].
    Arikan S; Darka O; Hasçelik G; Günalp A
    Mikrobiyol Bul; 2003 Jan; 37(1):49-57. PubMed ID: 12838678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of standard phenotypic assays with a PCR method to discriminate Candida albicans and C. dubliniensis.
    Mähnss B; Stehr F; Schäfer W; Neuber K
    Mycoses; 2005 Jan; 48(1):55-61. PubMed ID: 15679668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of isolation and drug susceptibility testing of non-Candida albicans species causing oropharyngeal candidiasis in HIV patients.
    Nadagir SD; Chunchanur SK; Halesh LH; Yasmeen K; Chandrasekhar MR; Patil BS
    Southeast Asian J Trop Med Public Health; 2008 May; 39(3):492-5. PubMed ID: 18564689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Candida dubliniensis: a novel emerging species].
    Anane S; Kallel K; Kaouech E; Belhaj S; Chaker E
    Ann Biol Clin (Paris); 2007; 65(1):13-9. PubMed ID: 17264034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Candida dubliniensis: Identification methods and epidemiologic implication].
    Khlif M; Sellami A; Sellami H; Makni F; Ayadi A
    Pathol Biol (Paris); 2011 Jun; 59(3):166-72. PubMed ID: 19046828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic and molecular characterization of Candida dubliniensis isolates from clinical specimens in Kuwait.
    Ahmad S; Mokaddas E; Al-Sweih N; Khan ZU
    Med Princ Pract; 2005; 14 Suppl 1():77-83. PubMed ID: 16103717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azole susceptibility and resistance in Candida dubliniensis.
    Pinjon E; Moran GP; Coleman DC; Sullivan DJ
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1210-4. PubMed ID: 16246083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isogenic strain construction and gene targeting in Candida dubliniensis.
    Staib P; Moran GP; Sullivan DJ; Coleman DC; Morschhäuser J
    J Bacteriol; 2001 May; 183(9):2859-65. PubMed ID: 11292806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candida dubliniensis: an emerging opportunistic pathogen.
    Sullivan D; Coleman D
    Curr Top Med Mycol; 1997 Dec; 8(1-2):15-25. PubMed ID: 9504063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular identification of Candida albicans and Candida dubliniensis strains isolated from clinical samples].
    Toraman ZA; Bulut Y; Yilmaz M; Ozdarendeli A
    Mikrobiyol Bul; 2005 Apr; 39(2):199-204. PubMed ID: 16128031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Candida dubliniensis: ten years on.
    Sullivan DJ; Moran GP; Coleman DC
    FEMS Microbiol Lett; 2005 Dec; 253(1):9-17. PubMed ID: 16213674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of phenotypic methods for the identification of Candida dubliniensis.
    Pasligh J; Radecke C; Fleischhacker M; Ruhnke M
    J Microbiol Immunol Infect; 2010 Apr; 43(2):147-54. PubMed ID: 20457432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDR1-mediated drug resistance in Candida dubliniensis.
    Wirsching S; Moran GP; Sullivan DJ; Coleman DC; Morschhäuser J
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3416-21. PubMed ID: 11709317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Candida dubliniensis at a cancer center.
    Sebti A; Kiehn TE; Perlin D; Chaturvedi V; Wong M; Doney A; Park S; Sepkowitz KA
    Clin Infect Dis; 2001 Apr; 32(7):1034-8. PubMed ID: 11264031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candida africana and its closest relatives.
    Romeo O; Criseo G
    Mycoses; 2011 Nov; 54(6):475-86. PubMed ID: 20667001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.